{
"info": {
"nct_id": "NCT02145026",
"official_title": "A Prospective Open-Label Study of the Effectiveness of Epoetin Beta for Treating Anemic Patients With Low/Intermediate-1-Risk Myelodysplastic Syndrome (MDS)",
"inclusion_criteria": "* Adult participants with low or intermediate-1 risk MDS\n* No previous treatment with hematopoietic growth factors within 3 months prior to screening\n* Symptomatic anemia (hemoglobin <10 g/dL) as determined by investigator\n* Serum erythropoietin <500 milliunits/milliliter (mU/mL) within 14 days prior to the first dose of study treatment\n* Require no red blood cell transfusion or dependent on <4 units within 8 weeks prior to screening\n* Clinically stable for at least 1 month prior to entry into the study\n* For female participants of childbearing potential and male participants with partners of childbearing potential, agreement (by participants and/or partner) to use highly effective form(s) of contraception\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Contraindications and/or known hypersensitivity to the active substance and/or any of the excipients of epoetin beta treatment\n* Poorly controlled hypertension as assessed by the investigator\n* History of Acute Myeloid Leukemia (AML) or high risk for AML\n* Administration of another investigational drug within 1 month before screening or planned during the study period\n* Previously documented evidence of Pure Red Cell Aplasia (PRCA)",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"identified_line": {
"line": "* Adult participants with low or intermediate-1 risk MDS",
"criterions": [
{
"exact_snippets": [
"Adult participants"
],
"criterion": "age",
"requirement_type": "category",
"expected_value": "adult"
},
{
"exact_snippets": [
"low or intermediate-1 risk MDS"
],
"criterion": "MDS risk",
"requirement_type": "category",
"expected_value": [
"low",
"intermediate-1"
]
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"Adult participants"
],
"criterion": "age",
"requirement_type": "category",
"expected_value": "adult"
},
{
"exact_snippets": [
"low or intermediate-1 risk MDS"
],
"criterion": "MDS risk",
"requirement_type": "category",
"expected_value": [
"low",
"intermediate-1"
]
}
]
}
},
{
"identified_line": {
"line": "* No previous treatment with hematopoietic growth factors within 3 months prior to screening",
"criterions": [
{
"exact_snippets": [
"No previous treatment with hematopoietic growth factors"
],
"criterion": "hematopoietic growth factors",
"requirement_type": "previous treatment",
"expected_value": false
},
{
"exact_snippets": [
"within 3 months prior to screening"
],
"criterion": "time since last treatment with hematopoietic growth factors",
"requirement_type": "duration",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 3
}
]
}
}
]
},
"logical_structure": {
"condition": {
"and_criteria": [
{
"exact_snippets": [
"No previous treatment with hematopoietic growth factors"
],
"criterion": "hematopoietic growth factors",
"requirement_type": "previous treatment",
"expected_value": false
},
{
"exact_snippets": [
"within 3 months prior to screening"
],
"criterion": "time since last treatment with hematopoietic growth factors",
"requirement_type": "duration",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 3
}
]
}
}
]
},
"then_criteria": null,
"else_criteria": {
"not_criteria": {
"and_criteria": [
{
"exact_snippets": [
"No previous treatment with hematopoietic growth factors"
],
"criterion": "hematopoietic growth factors",
"requirement_type": "previous treatment",
"expected_value": false
},
{
"exact_snippets": [
"within 3 months prior to screening"
],
"criterion": "time since last treatment with hematopoietic growth factors",
"requirement_type": "duration",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 3
}
]
}
}
]
}
}
}
},
{
"identified_line": {
"line": "* Symptomatic anemia (hemoglobin <10 g/dL) as determined by investigator",
"criterions": [
{
"exact_snippets": [
"Symptomatic anemia"
],
"criterion": "anemia",
"requirement_type": "symptom presence",
"expected_value": true
},
{
"exact_snippets": [
"hemoglobin <10 g/dL"
],
"criterion": "hemoglobin",
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 10
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"Symptomatic anemia"
],
"criterion": "anemia",
"requirement_type": "symptom presence",
"expected_value": true
},
{
"exact_snippets": [
"hemoglobin <10 g/dL"
],
"criterion": "hemoglobin",
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 10
}
}
]
}
},
{
"identified_line": {
"line": "* Serum erythropoietin <500 milliunits/milliliter (mU/mL) within 14 days prior to the first dose of study treatment",
"criterions": [
{
"exact_snippets": [
"Serum erythropoietin <500 milliunits/milliliter (mU/mL)"
],
"criterion": "serum erythropoietin",
"requirement_type": "quantity",
"expected_value": {
"comparisons": [
{
"operator": "<",
"value": 500
}
]
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"Serum erythropoietin <500 milliunits/milliliter (mU/mL)"
],
"criterion": "serum erythropoietin",
"requirement_type": "quantity",
"expected_value": {
"comparisons": [
{
"operator": "<",
"value": 500
}
]
}
}
]
}
},
{
"identified_line": {
"line": "* Require no red blood cell transfusion or dependent on <4 units within 8 weeks prior to screening",
"criterions": [
{
"exact_snippets": [
"no red blood cell transfusion"
],
"criterion": "red blood cell transfusion",
"requirement_type": "absence",
"expected_value": true
},
{
"exact_snippets": [
"dependent on <4 units within 8 weeks prior to screening"
],
"criterion": "red blood cell transfusion",
"requirement_type": "dependency",
"expected_value": {
"comparisons": [
{
"operator": "<",
"value": 4
}
]
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"not_criteria": {
"exact_snippets": [
"no red blood cell transfusion"
],
"criterion": "red blood cell transfusion",
"requirement_type": "absence",
"expected_value": true
}
},
{
"exact_snippets": [
"dependent on <4 units within 8 weeks prior to screening"
],
"criterion": "red blood cell transfusion",
"requirement_type": "dependency",
"expected_value": {
"comparisons": [
{
"operator": "<",
"value": 4
}
]
}
}
]
}
},
{
"identified_line": {
"line": "* Clinically stable for at least 1 month prior to entry into the study",
"criterions": [
{
"exact_snippets": [
"Clinically stable for at least 1 month"
],
"criterion": "clinical stability",
"requirement_type": "duration",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 1
}
]
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"Clinically stable for at least 1 month"
],
"criterion": "clinical stability",
"requirement_type": "duration",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 1
}
]
}
}
]
}
},
{
"identified_line": {
"line": "* For female participants of childbearing potential and male participants with partners of childbearing potential, agreement (by participants and/or partner) to use highly effective form(s) of contraception",
"criterions": [
{
"exact_snippets": [
"female participants of childbearing potential"
],
"criterion": "female participants",
"requirement_type": "childbearing potential",
"expected_value": true
},
{
"exact_snippets": [
"male participants with partners of childbearing potential"
],
"criterion": "male participants",
"requirement_type": "partners' childbearing potential",
"expected_value": true
},
{
"exact_snippets": [
"agreement (by participants and/or partner) to use highly effective form(s) of contraception"
],
"criterion": "contraception",
"requirement_type": "agreement to use",
"expected_value": true
}
]
},
"logical_structure": {
"condition": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": [
"female participants of childbearing potential"
],
"criterion": "female participants",
"requirement_type": "childbearing potential",
"expected_value": true
},
{
"exact_snippets": [
"agreement (by participants and/or partner) to use highly effective form(s) of contraception"
],
"criterion": "contraception",
"requirement_type": "agreement to use",
"expected_value": true
}
]
},
{
"and_criteria": [
{
"exact_snippets": [
"male participants with partners of childbearing potential"
],
"criterion": "male participants",
"requirement_type": "partners' childbearing potential",
"expected_value": true
},
{
"exact_snippets": [
"agreement (by participants and/or partner) to use highly effective form(s) of contraception"
],
"criterion": "contraception",
"requirement_type": "agreement to use",
"expected_value": true
}
]
}
]
},
"then_criteria": null,
"else_criteria": null
}
},
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": [
"Healthy volunteers allowed"
],
"criterion": "volunteer health status",
"requirement_type": "allowance",
"expected_value": true
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"Healthy volunteers allowed"
],
"criterion": "volunteer health status",
"requirement_type": "allowance",
"expected_value": true
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": [
"minimum age of 18 Years"
],
"criterion": "age",
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"minimum age of 18 Years"
],
"criterion": "age",
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18
}
}
]
}
}
],
"exclusion_lines": [
{
"identified_line": {
"line": "* Contraindications and/or known hypersensitivity to the active substance and/or any of the excipients of epoetin beta treatment",
"criterions": [
{
"exact_snippets": [
"Contraindications",
"to the active substance and/or any of the excipients of epoetin beta treatment"
],
"criterion": "contraindications",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"known hypersensitivity",
"to the active substance and/or any of the excipients of epoetin beta treatment"
],
"criterion": "hypersensitivity",
"requirement_type": "presence",
"expected_value": true
}
]
},
"logical_structure": {
"or_criteria": [
{
"or_criteria": [
{
"exact_snippets": [
"Contraindications",
"to the active substance and/or any of the excipients of epoetin beta treatment"
],
"criterion": "contraindications",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"known hypersensitivity",
"to the active substance and/or any of the excipients of epoetin beta treatment"
],
"criterion": "hypersensitivity",
"requirement_type": "presence",
"expected_value": true
}
]
}
]
}
},
{
"identified_line": {
"line": "* Poorly controlled hypertension as assessed by the investigator",
"criterions": [
{
"exact_snippets": [
"Poorly controlled hypertension"
],
"criterion": "hypertension",
"requirement_type": "control",
"expected_value": "poorly controlled"
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"Poorly controlled hypertension"
],
"criterion": "hypertension",
"requirement_type": "control",
"expected_value": "poorly controlled"
}
]
}
},
{
"identified_line": {
"line": "* History of Acute Myeloid Leukemia (AML) or high risk for AML",
"criterions": [
{
"exact_snippets": [
"History of Acute Myeloid Leukemia (AML)"
],
"criterion": "Acute Myeloid Leukemia (AML)",
"requirement_type": "history",
"expected_value": true
},
{
"exact_snippets": [
"high risk for AML"
],
"criterion": "Acute Myeloid Leukemia (AML)",
"requirement_type": "risk",
"expected_value": "high"
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": [
"History of Acute Myeloid Leukemia (AML)"
],
"criterion": "Acute Myeloid Leukemia (AML)",
"requirement_type": "history",
"expected_value": true
},
{
"exact_snippets": [
"high risk for AML"
],
"criterion": "Acute Myeloid Leukemia (AML)",
"requirement_type": "risk",
"expected_value": "high"
}
]
}
},
{
"identified_line": {
"line": "* Administration of another investigational drug within 1 month before screening or planned during the study period",
"criterions": [
{
"exact_snippets": [
"Administration of another investigational drug"
],
"criterion": "investigational drug",
"requirement_type": "administration",
"expected_value": true
},
{
"exact_snippets": [
"within 1 month before screening"
],
"criterion": "investigational drug administration",
"requirement_type": "timeframe",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 1
}
]
}
}
]
},
"logical_structure": {
"condition": {
"and_criteria": [
{
"exact_snippets": [
"Administration of another investigational drug"
],
"criterion": "investigational drug",
"requirement_type": "administration",
"expected_value": true
},
{
"exact_snippets": [
"within 1 month before screening"
],
"criterion": "investigational drug administration",
"requirement_type": "timeframe",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 1
}
]
}
}
]
},
"then_criteria": {
"exact_snippets": [
"planned during the study period"
],
"criterion": "investigational drug",
"requirement_type": "administration",
"expected_value": true
},
"else_criteria": null
}
},
{
"identified_line": {
"line": "* Previously documented evidence of Pure Red Cell Aplasia (PRCA)",
"criterions": [
{
"exact_snippets": [
"Previously documented evidence of Pure Red Cell Aplasia (PRCA)"
],
"criterion": "Pure Red Cell Aplasia (PRCA)",
"requirement_type": "documentation",
"expected_value": true
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": [
"Previously documented evidence of Pure Red Cell Aplasia (PRCA)"
],
"criterion": "Pure Red Cell Aplasia (PRCA)",
"requirement_type": "documentation",
"expected_value": true
}
}
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}